Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: DaiS who wrote (12198)	7/28/1998 9:40:00 AM
From: betty moyers	Respond to of 23519

Dais, looking at Q3 est We had EPS = 0.41 with US sales at 0.4 MM units INTL sales at 5.4 MM units If we use the ave of the past 3 weeks for US sales and assume no growth in that number then the EPS drops by 0.03 so EPS = 0.38 I see no evidence that US sales (while languishing) will drop to 0 but for hypothesis value if all US sales were translated to INTL sales then EPS would drop 0.11 thus EPS = 0.30 This assumes that all product made is indeed sold internationally. As to Q 4, it shadows Q3 partially. Would have to know how many lines open, how many milestone payments, etc. Think Q3 is as far as I want to look right now.